Lv2
160 积分 2023-11-25 加入
The burden and mortality impact of cardiovascular disease-metabolic dysfunction-associated steatotic liver disease comorbidity
2个月前
已完结
Cardiovascular, Renal, and Metabolic Outcomes of Dapagliflozin Versus Placebo in a Primary Cardiovascular Prevention Cohort: Analyses From DECLARE-TIMI 58
4个月前
已完结
Metabolic Dysfunction–Associated Steatotic Liver Disease
4个月前
已完结
Metabolic Dysfunction-Associated Steatotic Liver Disease in Adults: A Review
4个月前
已完结
Risk Prediction Model for Development of Heart Failure or Cardiomyopathy After Breast Cancer Treatment
4个月前
已完结
Modified Glomerular Filtration Rate Estimating Equation for Chinese Patients with Chronic Kidney Disease
5个月前
已完结
皖公网安备34019202002308
